Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat
- 30 April 1995
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 17 (4) , 255-263
- https://doi.org/10.1016/0192-0561(95)00012-q
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Suppressor cells of popliteal lymph node origin are involved in thein vivo andin vitro control of experimental allergic encephalomyelitis effector cells in the Lewis ratEuropean Journal of Immunology, 1991
- Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory diseaseImmunology Today, 1991
- T Cells Responsive to Myelin Basic Protein in Patients with Multiple SclerosisScience, 1990
- Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids.The Journal of Experimental Medicine, 1989
- Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis.The Journal of Experimental Medicine, 1988
- Interleukin-1 Stimulates the Secretion of Hypothalamic Corticotropin-Releasing FactorScience, 1987
- Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid HormonesScience, 1986
- T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelinationNature, 1985
- The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitisCellular Immunology, 1980
- CHEMICAL STUDIES ON AN ENCEPHALITOGENIC PROTEIN FROM GUINEA PIG BRAINAnnals of the New York Academy of Sciences, 1965